Pawel Baranczewski
Forskare vid Institutionen för farmaci; UDOPP
- Telefon:
- 018-471 40 67
- E-post:
- pawel.baranczewski@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Ladda ned kontaktuppgifter för Pawel Baranczewski vid Institutionen för farmaci; UDOPP
- CV:
- Ladda ned CV
Kort presentation
Associate Professor (Docent) in preclinical drug development. Head of the UDOPP (Uppsala University Drug Optimization and Pharmaceutical Profiling) local platform at the Department of Pharmacy, and the ADME of Therapeutics (ADMEoT) national facility within SciLifeLab Drug Discovery and Development.

Publikationer
Senaste publikationer
Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2024
- DOI för Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
- Ladda ner fulltext (pdf) av Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Ingår i Basic & Clinical Pharmacology & Toxicology, s. 153-164, 2024
- DOI för Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
- Ladda ner fulltext (pdf) av Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
Ingår i Basic & Clinical Pharmacology & Toxicology, 2024
- DOI för Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
- Ladda ner fulltext (pdf) av Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
Ingår i Science Advances, 2024
- DOI för AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Ladda ner fulltext (pdf) av AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
Ingår i Journal of chromatography. B, 2022
Alla publikationer
Artiklar i tidskrift
Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2024
- DOI för Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
- Ladda ner fulltext (pdf) av Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Ingår i Basic & Clinical Pharmacology & Toxicology, s. 153-164, 2024
- DOI för Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
- Ladda ner fulltext (pdf) av Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
Ingår i Basic & Clinical Pharmacology & Toxicology, 2024
- DOI för Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
- Ladda ner fulltext (pdf) av Population pharmacokinetic modelling of cetirizine concentrations in human breast milk: A contribution from the ConcePTION project
Ingår i Science Advances, 2024
- DOI för AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Ladda ner fulltext (pdf) av AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
Ingår i Journal of chromatography. B, 2022
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
Ingår i Nature Chemistry, s. 15-24, 2022
ENABLE: an engine for European antibacterial drug discovery and development
Ingår i Nature reviews. Drug discovery, s. 407-408, 2021
Ingår i Journal of Pharmaceutical Sciences, s. 2-11, 2021
Ingår i Scientific Reports, 2019
- DOI för Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
- Ladda ner fulltext (pdf) av Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Ingår i Nature Communications, 2018
- DOI för Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
- Ladda ner fulltext (pdf) av Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Ingår i Scientific Reports, 2018
- DOI för Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
- Ladda ner fulltext (pdf) av Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
Ingår i Science, s. 834-839, 2018
Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines
Ingår i MedChemComm, s. 1553-1560, 2017
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
Ingår i Journal of Medicinal Chemistry, s. 2148-2154, 2017
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors
Ingår i Journal of Medicinal Chemistry, s. 4279-4292, 2017
Validation and development of MTH1 inhibitors for treatment of cancer
Ingår i Annals of Oncology, s. 2275-2283, 2016
- DOI för Validation and development of MTH1 inhibitors for treatment of cancer
- Ladda ner fulltext (pdf) av Validation and development of MTH1 inhibitors for treatment of cancer
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Ingår i Journal of Medicinal Chemistry, s. 1140-1148, 2016
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Ingår i Nature, s. 215-221, 2014
Ingår i European Journal of Clinical Pharmacology, s. 167-178, 2014